Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor Cancer × Cisplatin × Other solid neoplasm × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 52 Mesothelioma 27 Unspecified Adult Solid Tumor, Protocol Specific 23 Solid Tumor 8 Advanced Solid Tumors 7 Advanced Solid Tumor 7 Solitary Fibrous Tumor, Pleural 6 Carcinoma, Non-Small-Cell Lung 5 Solid Tumors 3 Sarcoma 3 Neoplasms 3 Lung Neoplasms 3 Retinoblastoma 2 Prostatic Neoplasms 2 Peritoneal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Extensive Stage Small Cell Lung Cancer 2 Colonic Neoplasms 2 Breast Neoplasms 2 Advanced Solid Tumour 2 Uterine Cervical Neoplasms 1 Unspecified Childhood Solid Tumor, Protocol Specific 1 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumor Cancer 1 Small Cell Lung Carcinoma 1 Severe combined immunodeficiency with sensitivity to ionizing radiation 1 Rhabdomyosarcoma 1

Interventions

ispinesib 2 trametinib 1 irinotecan sucrosofate 1 Vincristine 1 Temozolomide 1 TP protocol 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Interleukin-18 1 Immunotherapy 1 Imatinib Mesylate 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡